RK
Rajesh Kumar Tiwari
About Rajesh Kumar Tiwari
Data last updated:
Rajesh Kumar Tiwari is a Director at Razenta Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Razenta Pharmaceuticals Private Limited reported revenue of ₹3.34 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 Sep 2021 | 2021 | ₹3.34 Cr (FY 2025) | Active |
Board colleagues of Rajesh Kumar Tiwari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nirmal Gangwani | 07731439 | Razenta Pharmaceuticals Private Limited | Additional Director |
| Pushpendra Kumar Tiwari | 09311930 | Razenta Pharmaceuticals Private Limited | Director |
| Yunus Ahamad | 09383899 | Razenta Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajesh Kumar Tiwari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajesh Kumar Tiwari
Rajesh Kumar Tiwari currently holds 1 directorship: Razenta Pharmaceuticals Private Limited (Director, since 08 Sep 2021, revenue ₹3.34 Cr (FY 2025)).
Rajesh Kumar Tiwari was first appointed on 08 Sep 2021 as Director at Razenta Pharmaceuticals Private Limited.
The current boards of Rajesh Kumar Tiwari's companies include Nirmal Gangwani (Razenta Pharmaceuticals Private Limited), Pushpendra Kumar Tiwari (Razenta Pharmaceuticals Private Limited), Yunus Ahamad (Razenta Pharmaceuticals Private Limited).